These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Su ZZ; Austin VN; Zimmer SG; Fisher PB Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744 [TBL] [Abstract][Full Text] [Related]
3. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells. Chambers AF; Behrend EI; Wilson SM; Denhardt DT Anticancer Res; 1992; 12(1):43-7. PubMed ID: 1567180 [TBL] [Abstract][Full Text] [Related]
5. Oncogene transformation and the metastatic phenotype. Chambers AF; Tuck AB Anticancer Res; 1988; 8(5A):861-71. PubMed ID: 3052258 [TBL] [Abstract][Full Text] [Related]
6. Tumorigenic and metastatic properties of two ras-oncogene transfected rat fibrosarcoma cell lines defective in c-jun. Marshall-Heyman H; Engel G; Ljungdahl S; Shoshan MC; Svensson C; Wasylyk B; Linder S Oncogene; 1994 Dec; 9(12):3655-63. PubMed ID: 7970724 [TBL] [Abstract][Full Text] [Related]
7. Transient alterations in the expression of protease and extracellular matrix genes during metastatic lung colonization by H-ras-transformed 10T1/2 fibroblasts. Gingras MC; Jarolim L; Finch J; Bowden GT; Wright JA; Greenberg AH Cancer Res; 1990 Jul; 50(13):4061-6. PubMed ID: 2191771 [TBL] [Abstract][Full Text] [Related]
8. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Hofmann M; Rudy W; Günthert U; Zimmer SG; Zawadzki V; Zöller M; Lichtner RB; Herrlich P; Ponta H Cancer Res; 1993 Apr; 53(7):1516-21. PubMed ID: 8453616 [TBL] [Abstract][Full Text] [Related]
9. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12. Teramoto H; Castellone MD; Malek RL; Letwin N; Frank B; Gutkind JS; Lee NH Oncogene; 2005 Jan; 24(3):489-501. PubMed ID: 15516973 [TBL] [Abstract][Full Text] [Related]
10. Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Behrend EI; Craig AM; Wilson SM; Denhardt DT; Chambers AF Cancer Res; 1994 Feb; 54(3):832-7. PubMed ID: 8306346 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of oncogene-mediated alterations in metastatic ability. Chambers AF Biochem Cell Biol; 1992 Sep; 70(9):817-21. PubMed ID: 1482559 [TBL] [Abstract][Full Text] [Related]
12. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Chi S; Kitanaka C; Noguchi K; Mochizuki T; Nagashima Y; Shirouzu M; Fujita H; Yoshida M; Chen W; Asai A; Himeno M; Yokoyama S; Kuchino Y Oncogene; 1999 Apr; 18(13):2281-90. PubMed ID: 10327074 [TBL] [Abstract][Full Text] [Related]
13. Resistance of murine LTA cells to oncogene--mediated progression from tumorigenic to metastatic phenotype. Tuck AB; Wilson SM; Chambers AF Anticancer Res; 1990; 10(6):1507-14. PubMed ID: 2285224 [TBL] [Abstract][Full Text] [Related]
14. The cell biology of ras-induced transformation: insights from studies utilizing an inducible hybrid oncogene system. Haliotis T; Trimble W; Chow S; Mills G; Girard P; Kuo JF; Govindji N; Hozumi N Anticancer Res; 1988; 8(5A):935-45. PubMed ID: 2845854 [TBL] [Abstract][Full Text] [Related]
15. [Cancer metastasis and oncogenes]. Taniguchi S Gan To Kagaku Ryoho; 1989 Oct; 16(10):3332-40. PubMed ID: 2679390 [TBL] [Abstract][Full Text] [Related]
16. [The relationship between metastatic phenotype and steady expression of BGC-Ha-ras oncogene from metastasis cell lines in nude mice (abstract)]. Li YJ Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):402-5. PubMed ID: 1349521 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091 [TBL] [Abstract][Full Text] [Related]
18. CD44 protein levels and its biological activity are regulated in Balb/c 3T3 fibroblasts by serum factors and by transformation with the ras but not with the sis oncogene. Kogerman P; Sy MS; Culp LA J Cell Physiol; 1996 Nov; 169(2):341-9. PubMed ID: 8908201 [TBL] [Abstract][Full Text] [Related]
19. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Urquidi V; Sloan D; Kawai K; Agarwal D; Woodman AC; Tarin D; Goodison S Clin Cancer Res; 2002 Jan; 8(1):61-74. PubMed ID: 11801541 [TBL] [Abstract][Full Text] [Related]
20. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. Garbisa S; Pozzatti R; Muschel RJ; Saffiotti U; Ballin M; Goldfarb RH; Khoury G; Liotta LA Cancer Res; 1987 Mar; 47(6):1523-8. PubMed ID: 3028610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]